Efficacy of apatinib combined with FOLFIRI in the first-line treatment of patients with metastatic colorectal cancer

Objective. To evaluate the efficacy and safety of apatinib combined with FOLFIRI in the first-line treatment of advanced metastatic colorectal cancer (mCRC) and explore potential factors of efficacy. Methods. Twenty mCRC patients treated at Affiliated Cancer Hospital of Shanxi Medical University fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rong, Xuetong, Liu, Haiyi, Yu, Hongmei, Zhao, Jian, Wang, Jie, Wang, Yusheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Phase II Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993747/
https://www.ncbi.nlm.nih.gov/pubmed/34997351
http://dx.doi.org/10.1007/s10637-021-01205-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993747/
https://www.ncbi.nlm.nih.gov/pubmed/34997351
http://dx.doi.org/10.1007/s10637-021-01205-3

Ejemplares similares